Disease Learning

VIDEO LIBRARIES

Emerging Options for T790M-Positive Acquired Resistance

Acquired resistance in EGFR patients is often driven by the T790M mutation. T790M-positive tumors respond differently to treatments than T790M-negative tumors. Dr. Greg Riely details how each status can predict patients' responses to current treatments.

Individual Treatments for Individual EGFR Mutations

There are sub-types within the sub-type of EGFR mutation positive lung cancer. In this presentation, Dr. Jack West discusses the different activating mutations within EGFR positive tumors and how they impact treatment.

Panel Q&A Session on ALK+ and ROS1 Acquired Resistance with Drs. Horn and Owonikoko

Janet Daily-Freeman moderates a question & answer session with Drs. Leora Horn and Taofeek Owonikoko on issues of acquired resistance to targeted therapies for ALK+ and ROS1 patients.

The Blood/Brain Barrier for ALK Patients

The brain is a common site of disease in patients with ALK+ lung cancer. In this video, Dr. Horn illustrates the line-up of ALK+ treatments and how they work breaking through the blood/brain barrier.

New Ideas and New Treatment Options for Acquired Resistance for ALK/ROS1

Xalkori (critzotinib) was the first approved treatment for ALK+ and ROS1 lung cancer. Since then, other drugs have been approved or are currently undergoing scientific review. In this video, Dr. Owonikoko outlines these options for patients.

ARTICLES

Dr. Ravi Salgia on "My Approach to Maintenance Therapy for Advanced NSCLC"

Dr. Ravi Salgia from University of Chicago provides his general strategy for patients with advanced non-small cell lung cancer who are candidates for...

Dr. William Pao on "How Concerned Should We Be About Different Testing Methods, as well as the Heterogeneity of Different Biopsy Results from the Same Patient?"

Dr. William Pao explains the caveats of molecular testing in terms of differences in testing methods through different laboratories and the...

Dr. David Harpole on Advances in Lung Cancer Surgical Techniques

The second part of the webinar by Dr. David Harpole of Duke University reviews advances in lung cancer surgery, covering techniques ranging from video...

Dr. Geoffrey Oxnard on Translating the Benefits of Molecular Oncology More Broadly: The Tissue is the Issue

Dr. Geoffrey Oxnard conveys a central theme that the benefits of molecular oncology and optimal application of targeted therapies are dependent on a...

Dr. David Harpole on Advances in Lung Cancer Staging

Here's the first of two podcasts from a webinar featuring expert thoracic surgeon Dr. David Harpole from Duke University. He and the Duke team have...